CorMedix Inc. Gains 24.08%
Mon, Sep 21, 2020 at 05:30 PM
CorMedix Inc. (CRMD:NYSEMKT) rocketted at $5.72, a gain of 24.1%. On Fri 18 Sep 20, CRMD:NYSEMKT hit a New 2-Week Intraday High of $4.97. The stock appeared on our News Catalysts scanner on Thu 17 Sep 20 at 09:38 AM in the 'INVESTOR UPDATE' category. From Fri 04 Sep 20, the stock recorded 55.56% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About CorMedix Inc. (CRMD:NYSEMKT)
Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 42.86%
- Cubic Corporation (CUB:NYSE), 34.23%
- CRDF (CRDF:NASDAQ), 33.18%
- Acasti Pharma Inc. (ACST:NASDAQ), 28.99%
- CorMedix Inc. (CRMD:NYSEMKT), 24.08%
- Roku, Inc. (ROKU:NASDAQ), 17.67%
- MicroVision, Inc. (MVIS:NASDAQ), 16.38%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 16.05%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 15.57%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 15.29%